Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Takeda Provides Update on Status of Acquisition of Own Shares
Takeda Announces Candidates for Board of Directors at Upcoming Shareholders Meeting
Protagonist and Takeda Announce Positive Topline Results from Phase 3 VERIFY Study of Rusfertide in Patients with Polycythemia Vera
Takeda Provides Update on Status of Acquisition of Own Shares
Julie Kim Will Succeed Christophe Weber as CEO of Takeda in June 2026
Takeda Pharma, The Current Fiscal Year Net Income Revised Upward by 74%
Earnings Report (Kessan Tanshin) for the Nine-month Period Ended December 31, 2024 (IFRS, Consolidated)
Notice of the Revised Forecast of Consolidated Financials for FY2024 (IFRS)
Takeda Announces Acquisition of Own Shares
Takeda Provides Update on Soticlestat (TAK-935)
Takeda Spotlights High-Value, Late-Stage Pipeline Accelerating the Development of Potential Transformative Treatments for Patients in Multiple TA
The 148th (interim period) Business Report
Semi-annual Securities Report (The semi-annual of 148th Business Term) for The Six-month Period Ended September 30, 2024
Takeda Pharmaceutical Company Limited, The Current Fiscal Year Net Income Revised Upward by 17%
Earnings Report (Kessan Tanshin) for the Six-month Period Ended September 30, 2024 (IFRS, Consolidated)
Notice of the Revised Forecast of Consolidated Financials for FY2024 (IFRS)